We, t2T Healthcare, and L.E.K. Consulting as well as Haihe Biopharma and Henlius Biotech jointly held a Japan promotion session for Chinese pharmaceutical companies titled “Opportunities for China Biopharma Clinical Development in Japan and Asia” at the second-day Main Program of “ChinaTrials16” which was held in Shanghai, China on November 11th (Mon) to 13th (Wed), 2024.

In this session, Mr. Tetsuomi Takano, President and CEO, t2T Healthcare Inc., made an introductory presentation titled “Japan’s Update in Regulatory and Clinical Study Environments for New Drug Development” and also participated in a panel discussion.